Wafik S El-Deiry (Wafik El-Deiry)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 37

Top Venues

bioRxiv : the preprint server for biology

Biochemical Society transactions

Medicina (Kaunas, Lithuania)

Journal of experimental & clinical cancer research : CR

Warren Alpert Medical School, Brown University

University of Miami School of Medicine (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Warren Alpert Medical School, Brown University Jan 01 2019

United States

Associate Dean, Oncologic Sciences :: Pathology/Lab Medicine and Medical Sciences

Fox Chase Cancer Center Oct 01 2014 - Dec 31 2018

United States

Deputy Director, Program Leader, Professor of Oncology :: Translational Medicine, Molecular Therapeutics, Hem/Onc

Penn State Milton S Hershey Medical Center Mar 01 2010 - Sep 30 2014

United States

Chief, Hematology/Oncology :: Medicine

University of Pennsylvania Jul 01 1994 - Feb 28 2010

United States

Professor of Medicine, Genetics, Pharmacology :: Medicine

Education History

University of Miami School of Medicine

United States

PHD

Publications

Elizabeth Ding, Maximillian Pinho-Schwermann, Shengliang Zhang, Connor Purcell, Wafik S El-Deiry
Neuroendocrine differentiation (ND) in sensitivity of neuroendocrine tumor (NET) cells to ONC201/TIC10 cancer therapeutic. bioRxiv : the preprint server for biology (2024)
Connor Purcell, Praveen R Srinivasan, Maximilian Pinho-Schwermann, William J MacDonald, Elizabeth Ding, Wafik S El-Deiry
Neuroendocrine Prostate Cancer Drivers SOX2 and BRN2 Confer Differential Responses to Imipridones ONC201, ONC206, and ONC212 in Prostate Cancer Cell Lines. bioRxiv : the preprint server for biology (2024)
Jessica Wagner, C Leah Kline, Lanlan Zhou, Vladimir Khazak, Wafik S El-Deiry
Correction: Anti-tumor effects of ONC201 in combination with VEGF-inhibitors significantly impacts colorectal cancer growth and survival in vivo through complementary non-overlapping mechanisms. Journal of experimental & clinical cancer research : CR 43 (1) (2024)
Maishara Muquith, Magdalena Espinoza, Andrew Elliott, Joanne Xiu, Andreas Seeber, Wafik S El-Deiry, Emmanuel S Antonarakis, Stephanie L Graff, Michael J Hall, Hossein Borghaei, Dave S B Hoon, Stephen V Liu, Patrick C Ma, Rana R McKay, Trisha Wise-Draper, John Marshall, George W Sledge, David Spetzler, Hao Zhu, David Hsiehchen
Tissue-specific thresholds of mutation burden associated with anti-PD-1/L1 therapy benefit and prognosis in microsatellite-stable cancers. Nature cancer 5 (7) (2024)
Maishara Muquith, Magdalena Espinoza, Andrew Elliott, Joanne Xiu, Andreas Seeber, Wafik S El-Deiry, Emmanuel S Antonarakis, Stephanie L Graff, Michael J Hall, Hossein Borghaei, Dave S B Hoon, Stephen V Liu, Patrick C Ma, Rana R McKay, Trisha Wise-Draper, John Marshall, George W Sledge, David Spetzler, Hao Zhu, David Hsiehchen
Tissue-specific thresholds of mutation burden associated with anti-PD-1/L1 therapy benefit and prognosis in microsatellite-stable cancers. Nature cancer (2024)
Dan Morgenstern-Kaplan, Samuel A Kareff, Asaad Trabolsi, Estelamari Rodriguez, Harris B Krause, Jennifer R Ribeiro, Heng Tan, Emmanuel S Antonarakis, Emil Lou, Misako Nagasaka, Sandra Algaze, Heinz-Josef Lenz, Stephen V Liu, Balazs Halmos, Dave S B Hoon, Peter Andreas Seeber, Patrick C Ma, Wafik S El-Deiry, Ari M VanderWalde, Gilberto de Lima Lopes
Genomic, immunologic, and prognostic associations of TROP2 (TACSTD2) expression in solid tumors. The oncologist (2024)
Enguang Yang, Suoshi Jing, Fang Wang, Hanzhang Wang, Shengjun Fu, Li Yang, Junqiang Tian, Dragan J Golijanin, Wafik S El-Deiry, Liang Cheng, Zhiping Wang
Mesenchymal stem cells in tumor microenvironment: drivers of bladder cancer progression through mitochondrial dynamics and energy production. Cell death & disease 15 (9) (2024)
Kelsey E Huntington, Anna D Louie, Praveen R Srinivasan, Christoph Schorl, Shaolei Lu, David Silverberg, Daniel Newhouse, Zhijin Wu, Lanlan Zhou, Brittany A Borden, Francis J Giles, Mark Dooner, Benedito A Carneiro, Wafik S El-Deiry
GSK-3 inhibitor elraglusib enhances tumor-infiltrating immune cell activation in tumor biopsies and synergizes with anti-PD-L1 in a murine model of colorectal cancer. bioRxiv : the preprint server for biology (2023)
Francesca Di Cristofano, Andrew George, Vida Tajiknia, Maryam Ghandali, Laura Wu, Yiqun Zhang, Praveen Srinivasan, Jillian Strandberg, Marina Hahn, Ashley Sanchez Sevilla Uruchurtu, Attila A Seyhan, Benedito A Carneiro, Lanlan Zhou, Kelsey E Huntington, Wafik S El-Deiry
Therapeutic targeting of TRAIL death receptors. Biochemical Society transactions 51 (1) (2023)
Francesca Di Cristofano, Andrew George, Vida Tajiknia, Maryam Ghandali, Laura Wu, Yiqun Zhang, Praveen Srinivasan, Jillian Strandberg, Marina Hahn, Ashley Sanchez Sevilla Uruchurtu, Attila A Seyhan, Benedito A Carneiro, Lanlan Zhou, Kelsey E Huntington, Wafik S El-Deiry
Therapeutic targeting of TRAIL death receptors. Biochemical Society transactions 51 (1) (2023)
Francesca Di Cristofano, Andrew George, Vida Tajiknia, Maryam Ghandali, Laura Wu, Yiqun Zhang, Praveen Srinivasan, Jillian Strandberg, Marina Hahn, Ashley Sanchez Sevilla Uruchurtu, Attila A Seyhan, Benedito A Carneiro, Lanlan Zhou, Kelsey E Huntington, Wafik S El-Deiry
Therapeutic targeting of TRAIL death receptors. Biochemical Society transactions (2023)
Kelsey E Huntington, Anna D Louie, Praveen R Srinivasan, Christoph Schorl, Shaolei Lu, David Silverberg, Daniel Newhouse, Zhijin Wu, Lanlan Zhou, Brittany A Borden, Francis J Giles, Mark Dooner, Benedito A Carneiro, Wafik S El-Deiry
GSK-3 inhibitor elraglusib enhances tumor-infiltrating immune cell activation in tumor biopsies and synergizes with anti-PD-L1 in a murine model of colorectal cancer. bioRxiv : the preprint server for biology (2023)
Kelsey E Huntington, Anna D Louie, Praveen R Srinivasan, Christoph Schorl, Shaolei Lu, David L Silverberg, Daniel Newhouse, Zhijin Wu, Lanlan Zhou, Brittany A Borden, Francis J Giles, Mark Dooner, Benedito Arruda Carneiro, Wafik S El-Deiry
GSK-3 Inhibitor Elraglusib Enhances Tumor-Infiltrating Immune Cell Activation in Tumor Biopsies and Synergizes with Anti-PD-L1 in a Murine Model of Colorectal Cancer. International journal of molecular sciences 24 (13) (2023)
Wafik S El-Deiry
Targeting Mutated p53: Naivete and Enthusiasm to Attempt the Impossible. Cancer research 83 (7) (2023)
Kelsey E Huntington, Anna D Louie, Praveen R Srinivasan, Christoph Schorl, Shaolei Lu, David Silverberg, Daniel Newhouse, Zhijin Wu, Lanlan Zhou, Brittany A Borden, Francis J Giles, Mark Dooner, Benedito A Carneiro, Wafik S El-Deiry
GSK-3 inhibitor elraglusib enhances tumor-infiltrating immune cell activation in tumor biopsies and synergizes with anti-PD-L1 in a murine model of colorectal cancer. bioRxiv : the preprint server for biology (2023)
Francesca Di Cristofano, Andrew George, Vida Tajiknia, Maryam Ghandali, Laura Wu, Yiqun Zhang, Praveen Srinivasan, Jillian Strandberg, Marina Hahn, Ashley Sanchez Sevilla Uruchurtu, Attila A Seyhan, Benedito A Carneiro, Lanlan Zhou, Kelsey E Huntington, Wafik S El-Deiry
Therapeutic targeting of TRAIL death receptors. Biochemical Society transactions 51 (1) (2023)
Francesca Di Cristofano, Andrew George, Vida Tajiknia, Maryam Ghandali, Laura Wu, Yiqun Zhang, Praveen Srinivasan, Jillian Strandberg, Marina Hahn, Ashley Sanchez Sevilla Uruchurtu, Attila A Seyhan, Benedito A Carneiro, Lanlan Zhou, Kelsey E Huntington, Wafik S El-Deiry
Therapeutic targeting of TRAIL death receptors. Biochemical Society transactions 51 (1) (2023)
Sourat Darabi, David R Braxton, Joanne Xiu, Benedito Arruda Carneiro, Jeff Swensen, Emmanuel S Antonarakis, Stephen V Liu, Rana R McKay, David Spetzler, Wafik S El-Deiry, Michael J Demeure
BRCA1/2 Reversion Mutations in Patients Treated with Poly ADP-Ribose Polymerase (PARP) Inhibitors or Platinum Agents. Medicina (Kaunas, Lithuania) 58 (12) (2022)
Sourat Darabi, David R Braxton, Joanne Xiu, Benedito Arruda Carneiro, Jeff Swensen, Emmanuel S Antonarakis, Stephen V Liu, Rana R McKay, David Spetzler, Wafik S El-Deiry, Michael J Demeure
BRCA1/2 Reversion Mutations in Patients Treated with Poly ADP-Ribose Polymerase (PARP) Inhibitors or Platinum Agents. Medicina (Kaunas, Lithuania) 58 (12) (2022)
Sourat Darabi, David R Braxton, Joanne Xiu, Benedito Arruda Carneiro, Jeff Swensen, Emmanuel S Antonarakis, Stephen V Liu, Rana R McKay, David Spetzler, Wafik S El-Deiry, Michael J Demeure
BRCA1/2 Reversion Mutations in Patients Treated with Poly ADP-Ribose Polymerase (PARP) Inhibitors or Platinum Agents. Medicina (Kaunas, Lithuania) 58 (12) (2022)
Kelsey E Huntington, Lindsey Carlsen, Eui-Young So, Matthias Piesche, Olin Liang, Wafik S El-Deiry
Integrin/TGF-β1 Inhibitor GLPG-0187 Blocks SARS-CoV-2 Delta and Omicron Pseudovirus Infection of Airway Epithelial Cells In Vitro, Which Could Attenuate Disease Severity. Pharmaceuticals (Basel, Switzerland) 15 (5) (2022)
Sourat Darabi, David R Braxton, Joanne Xiu, Benedito Arruda Carneiro, Jeff Swensen, Emmanuel S Antonarakis, Stephen V Liu, Rana R McKay, David Spetzler, Wafik S El-Deiry, Michael J Demeure
BRCA1/2 Reversion Mutations in Patients Treated with Poly ADP-Ribose Polymerase (PARP) Inhibitors or Platinum Agents. Medicina (Kaunas, Lithuania) 58 (12) (2022)
Shengliang Zhang, Lindsey Carlsen, Liz Hernandez Borrero, Attila A Seyhan, Xiaobing Tian, Wafik S El-Deiry
Advanced Strategies for Therapeutic Targeting of Wild-Type and Mutant p53 in Cancer. Biomolecules 12 (4) (2022)
Sourat Darabi, David R Braxton, Joanne Xiu, Benedito Arruda Carneiro, Jeff Swensen, Emmanuel S Antonarakis, Stephen V Liu, Rana R McKay, David Spetzler, Wafik S El-Deiry, Michael J Demeure
BRCA1/2 Reversion Mutations in Patients Treated with Poly ADP-Ribose Polymerase (PARP) Inhibitors or Platinum Agents. Medicina (Kaunas, Lithuania) 58 (12) (2022)
Lindsey Carlsen, Kelsey E Huntington, Wafik S El-Deiry
Immunotherapy for Colorectal Cancer: Mechanisms and Predictive Biomarkers. Cancers 14 (4) (2022)
Andrew George, Ilyas Sahin, Benedito A Carneiro, Don S Dizon, Howard P Safran, Wafik S El-Deiry
Strategies to sensitize cancer cells to immunotherapy. Human vaccines & immunotherapeutics 17 (8) (2021)
Suchitra Kamle, Bing Ma, Chuan Hua He, Bedia Akosman, Yang Zhou, Chang-Min Lee, Wafik S El-Deiry, Kelsey Huntington, Olin Liang, Jason T Machan, Min-Jong Kang, Hyeon Jun Shin, Emiko Mizoguchi, Chun Geun Lee, Jack A Elias
Chitinase 3-like-1 is a Therapeutic Target That Mediates the Effects of Aging in COVID-19. bioRxiv : the preprint server for biology (2021)
Lindsey Carlsen, Wafik S El-Deiry
Differential p53-Mediated Cellular Responses to DNA-Damaging Therapeutic Agents. International journal of molecular sciences 22 (21) (2021)
Kelsey E Huntington, Anna D Louie, Chun Geun Lee, Jack A Elias, Eric A Ross, Wafik S El-Deiry
Cytokine ranking via mutual information algorithm correlates cytokine profiles with presenting disease severity in patients infected with SARS-CoV-2. eLife 10 (2021)
Liz Hernandez Borrero, David T Dicker, John Santiago, Jennifer Sanders, Xiaobing Tian, Nagib Ahsan, Avital Lev, Lanlan Zhou, Wafik S El-Deiry
A subset of CB002 xanthine analogs bypass p53-signaling to restore a p53 transcriptome and target an S-phase cell cycle checkpoint in tumors with mutated-p53. eLife 10 (2021)
Jocelyn E Ray, Marie D Ralff, Aakash Jhaveri, Lanlan Zhou, David T Dicker, Eric A Ross, Wafik S El-Deiry
Antitumorigenic effect of combination treatment with ONC201 and TRAIL in endometrial cancer in vitro and in vivo. Cancer biology & therapy (2021)
Ilyas Sahin, Shengliang Zhang, Arunasalam Navaraj, Lanlan Zhou, Don Dizon, Howard Safran, Wafik S El-Deiry
Correction: AMG-232 sensitizes high MDM2-expressing tumor cells to T-cell-mediated killing. Cell death discovery 6 (2020)
Benedito A Carneiro, Wafik S El-Deiry
Targeting apoptosis in cancer therapy. Nature reviews. Clinical oncology 17 (7) (2020)
Ilyas Sahin, Shengliang Zhang, Arunasalam Navaraj, Lanlan Zhou, Don Dizon, Howard Safran, Wafik S El-Deiry
AMG-232 sensitizes high MDM2-expressing tumor cells to T-cell-mediated killing. Cell death discovery 6 (2020)
Arthur Winer, Pooja Ghatalia, Nicole Bubes, Fern Anari, Asya Varshavsky, Vineela Kasireddy, Yang Liu, Wafik S El-Deiry
Dual Checkpoint Inhibition with Ipilimumab plus Nivolumab After Progression on Sequential PD-1/PDL-1 Inhibitors Pembrolizumab and Atezolizumab in a Patient with Lynch Syndrome, Metastatic Colon, and Localized Urothelial Cancer. The oncologist 24 (11) (2019)
Jessica Wagner, C Leah Kline, Lanlan Zhou, Vladimir Khazak, Wafik S El-Deiry
Anti-tumor effects of ONC201 in combination with VEGF-inhibitors significantly impacts colorectal cancer growth and survival in vivo through complementary non-overlapping mechanisms. Journal of experimental & clinical cancer research : CR 37 (1) (2018)
Varun V Prabhu, Amriti R Lulla, Neel S Madhukar, Marie D Ralff, Dan Zhao, Christina Leah B Kline, A Pieter J Van den Heuvel, Avital Lev, Mathew J Garnett, Ultan McDermott, Cyril H Benes, Tracy T Batchelor, Andrew S Chi, Olivier Elemento, Joshua E Allen, Wafik S El-Deiry
Cancer stem cell-related gene expression as a potential biomarker of response for first-in-class imipridone ONC201 in solid tumors. PloS one 12 (8) (2017)

Wafik S El-Deiry.css-eqlu8i{font-size:small;padding-left:4px;} (Wafik El-Deiry)

Publication Activity (10 Years)

Top Topics

Top Venues

Wafik S El-Deiry (Wafik El-Deiry)